Hims & Hers Health (HIMS) Tax Provisions (2020 - 2026)
Hims & Hers Health (HIMS) reported Tax Provisions of -$9.4 million for Q1 2026, down 185.7% on a YoY basis from $11.0 million in Q1 2025, and down 319.75% sequentially from -$2.2 million in Q4 2025.
Hims & Hers Health (HIMS) Tax Provisions (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Tax Provisions data on file, last reported at -$9.4 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 185.7% year-over-year to -$9.4 million; the trailing twelve-month figure through Mar 2026 stood at -$24.9 million (up 44.19% YoY), and the FY2025 full-year result was -$4.4 million, up 91.83% from the prior year.
- Tax Provisions eased to -$9.4 million in Q1 2026, from -$2.2 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $11.0 million in Q1 2025 to a low of -$52.0 million in Q3 2024.
- A 5-year average of -$3.9 million and a median of -$13000.0 in 2023 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions surged 4168.75% in 2023 and slumped 8086.94% in 2024, its largest moves.
- Tracing HIMS's Tax Provisions over 5 years: stood at -$121000.0 in 2022, then surged by 885.95% to $951000.0 in 2023, then tumbled by 492.64% to -$3.7 million in 2024, then soared by 39.8% to -$2.2 million in 2025, then slumped by 319.75% to -$9.4 million in 2026.
- Business Quant data shows HIMS's Tax Provisions at -$9.4 million in Q1 2026, -$2.2 million in Q4 2025, and -$3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -9.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.44 Mn |
| Dec 31, 2025 | -2.25 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | -9.65 Mn |
| Mar 31, 2025 | 11.01 Mn |
| Dec 31, 2024 | -3.73 Mn |
| Sep 30, 2024 | -52.00 Mn |
| Jun 30, 2024 | 127,000.00 |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 951,000.00 |
| Sep 30, 2023 | 651,000.00 |
| Jun 30, 2023 | -13,000.00 |
| Mar 31, 2023 | 386,000.00 |
| Dec 31, 2022 | -121,000.00 |
| Sep 30, 2022 | -16,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 94,000.00 |
| Dec 31, 2021 | -87,000.00 |
| Sep 30, 2021 | -3.17 Mn |
| Jun 30, 2021 | 34,000.00 |